ASX:RHT

Resonance Health - MRI for the masses

Stuart Roberts
Stuart Roberts NDF Research

In December 2016 NDF Research initiated coverage on Resonance Health (ASX: RHT), a Perth-based company which developed the world’s first non-invasive diagnostic for iron overload, an MRI-based test called FerriScan. This test, which gained both CE Mark and FDA approval in January 2005, has been the basis of a small... Show More

life sciences ASX:RHT NDF Research ndfresearch.com/blog

Resonance Health - World-leading MRI diagnostics

Stuart Roberts
Stuart Roberts NDF Research

Last week NDF Research initiated coverage on Resonance Health, a Perth-based company which over a decade ago developed the world’s first non-invasive diagnostic for iron overload, an MRI-based test called FerriScan. This test, approved in the US and Europe since 2005, has been the basis of a small but growing... Show More

life sciences ASX:RHT NDF Research ndfresearch.com/blog

Continuing the search for undiscovered healthcare stocks

Scott Power
Scott Power Morgans

Resonance (RHT) is an Australian healthcare company specialising in the development and delivery of non-invasive medical imaging software and services. We are continuing to search for undiscovered healthcare stocks, particularly those which have approved products and generating revenues. We have made no formal recommendation or valuation on RHT, we simply... Show More

healthcare Resonance ASX:RHT